Xavier Repessé1, Antoine Vieillard-Baron1,2,3. 1. Intensive Care Unit, Section Thorax-Vascular Disease-Abdomen-Metabolism, University Hospital Ambroise Paré, Boulogne-Billancourt, France. 2. Faculty of Medicine Paris Ile-de-France Ouest, University of Versailles Saint-Quentin en Yvelines, Saint-Quentin en Yvelines, France. 3. INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France.
Authors: Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-01-13 Impact factor: 5.464
Authors: J G Laffey; M Tanaka; D Engelberts; X Luo; S Yuan; A K Tanswell; M Post; T Lindsay; B P Kavanagh Journal: Am J Respir Crit Care Med Date: 2000-12 Impact factor: 21.405
Authors: Antoine Vieillard-Baron; Cyril Charron; Vincent Caille; Guillaume Belliard; Bernard Page; François Jardin Journal: Chest Date: 2007-10-09 Impact factor: 9.410
Authors: Sebastian Prin; Karim Chergui; Rock Augarde; Bernard Page; François Jardin; Antoine Vieillard-Baron Journal: Intensive Care Med Date: 2002-10-08 Impact factor: 17.440
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Scott E Sinclair; David A Kregenow; Wayne J E Lamm; Ian R Starr; Emil Y Chi; Michael P Hlastala Journal: Am J Respir Crit Care Med Date: 2002-08-01 Impact factor: 21.405